Aris Moschovitis

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

Marco Valgimigli, Enrico Frigoli, Dik Heg et al. · New England Journal of Medicine · 2021 · 507 citations · Full text

Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction

Lorenz Räber, Henning Kelbæk, Miodrag Ostojić et al. · JAMA · 2012 · 295 citations

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

Thomas Pilgrim, Dik Heg, Marco Roffi et al. · The Lancet · 2014 · 263 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Percutaneous Coronary Revascularisation +7

Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study

Fabien Praz, Konstantinos Spargias, Michael Chrissoheris et al. · The Lancet · 2017 · 222 citations

Compassionate Use, Heart Failure, First-in-man Study +7